Elucidation of the mechanisms of gene expression regulation and development of novel therapeutic and diagnostic methods for cancer, based on the results
We are elucidating the mechanisms of gene expression through the complex interactions of multiple factors. We are also developing new therapeutic and evaluation methods for cancer based on the results of these studies.
Genome biology、Gene Therapy Science、Cancer biology
Bioinformatics、Next generation sequencing、Novel therapeutic molecules
In previous studies, we found that the novel histone methyltransferase Whsc1, identified from a database screening, functions cooperatively with the transcription factor Nkx2-5 and is the causative gene for Wolf-Hirschhorn syndrome with congenital heart disease (Nature 2009, PLoS One 2014). We found that Nkx2-5 governs chromatin structure and cooperatively terminates transcription with the transcription termination factor Xrn2 (eLife 2016). While studying in the U.S., we revealed a mechanism for rapid decondensation of chromatin structure (Mol. Cell 2017). In our research on mechanisms of gene expression regulation in cancer, we identified alternative RNA splicing regulatory mechanisms that exacerbate tumors and developed methods to control them (Cancer Res. 2019, Tetrahedron Letters 2019, ACS Medicinal Chemistry Letters 2020, Cell & Bioscience 2022). We revealed the mechanism of cancer stem cell emergence in cancer cell populations using a gene expression recording method combining DNA barcoding and Cas9/self-targeted gRNAs (Cellular and Molecular Life Sciences, 2022). Furthermore, we are working to elucidate the mechanisms of gene expression regulation that induce the antitumor effects of non-proliferative virotherapy. We are developing novel anticancer drugs based on these mechanisms of action.